WallStreetZenWallStreetZen

NASDAQ: FGEN
Fibrogen Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Be the first to know when Wall Street analysts revise their FGEN stock forecasts and price targets.

Forecast return on equity

Is FGEN forecast to generate an efficient return?
Insufficient data to display

Forecast return on assets

Is FGEN forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

FGEN revenue forecast

What is FGEN's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$172.0M+16.41%
Avg 2 year Forecast
$196.0M+32.65%
Avg 3 year Forecast
$216.0M+46.19%
FGEN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

FGEN revenue growth forecast

How is FGEN forecast to perform vs Biotechnology companies and vs the US market?
Company
13.61%
Industry
37.5%
Market
10.08%
FGEN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
FGEN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

FGEN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
FGEN$0.98N/AN/A
BRNS$2.51$8.00+218.73%Buy
IOBT$1.46$8.00+447.95%Buy
ORMP$2.37N/AN/A
CLRB$3.06$20.00+553.59%Strong Buy
View Top Biotech Stocks

Fibrogen Stock Forecast FAQ

What is FGEN's revenue growth forecast for 2024-2026?

(NASDAQ: FGEN) Fibrogen's forecast annual revenue growth rate of 13.61% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.5%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.08%.

Fibrogen's revenue in 2024 is $147,752,000.On average, 1 Wall Street analysts forecast FGEN's revenue for 2024 to be $16,988,654,484, with the lowest FGEN revenue forecast at $16,988,654,484, and the highest FGEN revenue forecast at $16,988,654,484. On average, 1 Wall Street analysts forecast FGEN's revenue for 2025 to be $19,359,164,412, with the lowest FGEN revenue forecast at $19,359,164,412, and the highest FGEN revenue forecast at $19,359,164,412.

In 2026, FGEN is forecast to generate $21,334,589,352 in revenue, with the lowest revenue forecast at $21,334,589,352 and the highest revenue forecast at $21,334,589,352.

If you're new to stock investing, here's how to buy Fibrogen stock.

What is FGEN's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: FGEN) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is FGEN's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: FGEN) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.